2000
DOI: 10.1016/s0027-5107(00)00033-6
|View full text |Cite
|
Sign up to set email alerts
|

Sister-chromatid exchange frequencies in postmenopausal hormone replacement patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2004
2004
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 10 publications
0
5
0
Order By: Relevance
“…However, the composition of the OCs can vary from country to country so as the response toward the drugs forms the basis of pharmacogenomics [30]. The reports on the genotoxic potential in women's using steroid hormones as an OCs or HRT are available [31,32]. In the present study the serum enzymes studied are liver enzymes that are present normally inside the hepatocytes and are released into the blood when there is hepatocellular damage.…”
Section: Discussionmentioning
confidence: 94%
“…However, the composition of the OCs can vary from country to country so as the response toward the drugs forms the basis of pharmacogenomics [30]. The reports on the genotoxic potential in women's using steroid hormones as an OCs or HRT are available [31,32]. In the present study the serum enzymes studied are liver enzymes that are present normally inside the hepatocytes and are released into the blood when there is hepatocellular damage.…”
Section: Discussionmentioning
confidence: 94%
“…This value was not significant in comparison with those of the negative control which was 19.91%. The CAs noticed in this study was breaks, ring, dysenteric and a centric which appeared when using different concentrations of COCPs figure (3,4).…”
Section: B -Chromosomal Aberrationmentioning
confidence: 61%
“…Due to the fact that the full mechanism of the action of these agents is not totally understood, it is important that the long term genetic effects of OC usage be thoroughly investigated and documented. Some recent publication has suggested that exposure to sex steroids and oral contraceptives OCs during pregnancy may possibly cause congenital defects in human infants exposed in utero [4]. Since estrogens and progestogens are known to affect many metabolic and biochemical systems (it is possible that these substances may induce in OC users and pregnant women, a slightly altered in vivo condition, in which increased chromosome breakages may be expressed).…”
Section: Comparison With Those Of the Negative Control Which Was 1991% Higher Doses Of Ocps May Cause Cytogenetic Effects In Chromosomal mentioning
confidence: 99%
“…It was reported that SCE frequency in women who took progesterone-contained estrogens and withoutprogesterone-contained estrogens was high, and this may increase malignancy potential. This group of women was at postmenopausal period during hormone replacement treatment (Kayıkçıoğlu et al, 2000). Therefore, they reported that estrogens may exhibit a genotoxic effect (Kayıkçıoğlu et al, 2000;Şahin et al, 2000).…”
Section: Discussionmentioning
confidence: 99%
“…This group of women was at postmenopausal period during hormone replacement treatment (Kayıkçıoğlu et al, 2000). Therefore, they reported that estrogens may exhibit a genotoxic effect (Kayıkçıoğlu et al, 2000;Şahin et al, 2000). In addition, contraceptive use was found to increase the SCE frequency in some studies.…”
Section: Discussionmentioning
confidence: 99%